Astrana Health (ASTH) Gross Margin (2010 - 2026)

Astrana Health has disclosed Gross Margin across 17 years of filings, most recently posting 10.96% for Q1 2026.

• Gross Margin for Q1 2026 came in at 10.96%, down 54.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 10.66% (down 128.0% YoY), and the FY2025 annual result was 10.73%, down 261.0% from the prior year.
• Gross Margin came in at 10.96% for Q1 2026 at Astrana Health, up from 10.0% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 24.05% in Q3 2022 to a low of 7.59% in Q4 2024.
• The 5-year median for Gross Margin is 14.19% (2023), against an average of 14.22%.
• Across the five-year window, Gross Margin plunged 1102 bps in 2022 and jumped 410 bps in 2024, its largest moves.
• Astrana Health's Gross Margin stood at 13.97% in 2022, then slipped by 21 bps to 11.04% in 2023, then plunged by 31 bps to 7.59% in 2024, then surged by 32 bps to 10.0% in 2025, then rose by 10 bps to 10.96% in 2026.
• The last three Gross Margin figures came in at 10.96% (Q1 2026), 10.0% (Q4 2025), and 10.17% (Q3 2025), per Business Quant data.